To analyze the possible role of human herpesvirus (HHVs) and human endogenous retroviruses (HERVs) infection in multiple sclerosis (MS) pathogenesis.
Methods
A total of 92 cerebrospinal fluid (CSF) samples were collected: 48 from MS patients at the first clinically evident demyelinating event, 23 from patients with other inflammatory neurological diseases (OINDs) and 21 from patients with other non-inflammatory neurological diseases (ONINDs). Total DNA and RNA were isolated, and the prevalences and viral loads of herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein–Barr virus (EBV), cytomegalovirus (CMV), HHV-6, HERV-H and HERV-W in the CSF of MS patients and controls were evaluated using a quantitative real-time polymerase chain reaction assay.
Results
(i) For HSV, 1/48 (2.1%, 86 copies/ml of CSF) MS patients and 1/23 (4.3%, 115.2 copies/ml of CSF) OIND patients (a myelitis case) had HSV sequences in the CSF; (ii) for EBV, only 1/48 (2.1%, 72 copies/ml of CSF) MS patients was positive for EBV; (iii) for HHV-6, only 5/48 (10.4%) MS patients had HHV-6 genomes in their CSF (128.1 copies/ml of CSF); (iv) we did not find any positive cases for VZV, CMV, HERV-H and HERV-W among MS patients or controls; (v) no cases of co-infections were found; (vi) the whole prevalence of HHVs was 7/48 (14.6%) for MS patients and 1/44 (2.3%) for controls (p = 0.038).
Conclusion
The findings described here show that HHV infection is more frequent in the CSF of MS patients than in patients with other neurological diseases; however, only HHV-6 seems to be involved in the pathogenesis of MS in a subset of patients.
1 Berti R Jacobson S . Role of viral infection in the aetiology of multiple sclerosis. Status of current knowledge and therapeutic implications.CNS Drugs1999; 12: 1 – 7 .
2.
2 Johnson RT . The virology of demyelinating diseases.Ann Neurol1994; 36: S54 – S60 .
3.
3 Ascherio A Munger KL . Environmental risk factors for multiple sclerosis. Part I: the role of infection.Ann Neurol2007; 61: 288 – 299 .
4.
4 Cleator GM Klapper PE . The herpesviridae. In: AJ ZuckermanJE BanatvalaJR Pattison , (eds). Principles and practice of clinical virology, third edition. New York : John Wiley & Sons , 1995: 1–3.
5.
5 Hawkes CH Giovannoni G Keir G Cunnington M Thompson EJ . Seroprevalence of herpes simplex virus type 2 in multiple sclerosis.Acta Neurol Scand2006; 114: 363 – 367 .
6.
6 Bello-Morales R Fedetz M Alcina A Tabares E Lopez-Guerrero JA . High susceptibility of a human oligodendroglial cell line to herpes simplex type 1 infection.J Neurovirol2005; 11: 190 – 198 .
7.
7 Nielsen TR Pedersen M Rostgaard K Frisch M Hjalgrim H . Correlations between Epstein–Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals.Mult Scler2007; 13: 420 – 423 .
8.
8 Pohl D Krone B Rostasy K Kahler E Brunner E Lehnert M . High seroprevalence of Epstein–Barr virus in children with multiple sclerosis.Neurology2006; 67: 2063 – 2065 .
9.
9 DeLorenze GN Munger KL Lennette ET Orentreich N Vogelman JH Ascherio A . Epstein–Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.Arch Neurol2006; 63: 839 – 844 .
10.
10 Lunemann JD Edwards N Muraro PA Hayashi S Cohen JI Munz C . Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.Brain2006; 129: 1493 – 1506 .
11.
11 Hollsberg P Kusk M Bech E Hansen HJ Jakobsen J Haahr S . Presence of Epstein–Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.Acta Neurol Scand2005; 112: 395 – 402 .
12.
12 Levin LI Munger KL Rubertone MV Peck CA Lennette ET Spiegelman D . Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.JAMA2005; 293: 2496 – 2500 .
13.
13 Cepok S Zhou D Srivastava R Nessler S Stei S Bussow K . Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.J Clin Invest2005; 115: 1352 – 1360 .
14.
14 Mancuso R Delbue S Borghi E Pagani E Calvo MG Caputo D . Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis.J Med Virol2007; 79: 192 – 199 .
15.
15 Sotelo J Ordonez G Pineda B . Varicella-zoster virus at relapses of multiple sclerosis.J Neurol2007; 254: 493 – 500 .
16.
16 Ordonez G Pineda B Garcia-Navarrete R Sotelo J . Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis.Arch Neurol2004; 61: 529 – 532 .
17.
17 Thewissen M Somers V Venken K Linsen L van Paassen P Geusens P . Analyses of immunosenescent markers in patients with autoimmune disease.Clin Immunol2007; 123: 209 – 218 .
18.
18 Zivadinov R Nasuelli D Tommasi MA Serafin M Bratina A Ukmar M . Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients.Neurol Res2006; 28: 262 – 269 .
19.
19 Alvarez-Lafuente R de las Heras V Garcia-Montojo M Bartolome M Arroyo R . Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive.Mult Scler2007; 13: 578 – 583 .
20.
20 Alvarez-Lafuente R Garcia-Montojo M De las Heras V Bartolome M Arroyo R . Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients.J Clin Virol2006; 37: S24 – S26 .
21.
21 Gardell JL Dazin P Islar J Menge T Genain CP Lalive PH . Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity.J Clin Virol2006; 37: S11 – S16 .
22.
22 Akhyani N Fotheringham J Yao K Rashti F Jacobson S . Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.J Neurovirol2006; 12: 284 – 293 .
23.
23 Alvarez-Lafuente R De Las Heras V Bartolome M Garcia-Montojo M Arroyo R . Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.Brain Pathol2006; 16: 20 – 27 .
24.
24 Yao K Mandel M Akyani N Maynard K Sengamalay N Fotheringham J . Differential HHV-6A gene expression in T cells and primary human astrocytes based on multi-virus array analysis.Glia2006; 53: 789 – 798 .
25.
25 Ahlqvist J Fotheringham J Akhyani N Yao K Fogdell-Hahn A Jacobson S . Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes.J Neurovirol2005; 11: 384 – 394 .
26.
26 Friedman JE Zabriskie JB Plank C Ablashi D Whitman J Shahan B . A randomized clinical trial of valacyclovir in multiple sclerosis.Mult Scler2005; 11: 286 – 295 .
27.
27 Meeuwsen S Persoon-Deen C Bsibsi M Bajramovic JJ Ravid R . Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A.J Neuroimmunol2005; 164: 37 – 47 .
28.
28 Fogdell-Hahn A Soldan SS Shue S Akhyani N Refai H Ahlqvist J . Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients.Virus Res2005; 110: 57 – 63 .
29.
29 Derfuss T Hohlfeld R Meinl E . Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response.J Neurol2005; 252: 968 – 971 .
30.
30 Virtanen JO Zabriskie JB Siren V Friedman JE Lyons MJ Edgar M . Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue.Med Sci Monit2005; 11: BR84 – BR87 .
31.
31 Antony JM Ellestad KK Hammond R Imaizumi K Mallet F Warren KG . The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes.J Immunol2007; 179: 1210 – 1224 .
32.
32 Mameli G Astone V Arru G Marconi S Lovato L Serra C . Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.J Gen Virol2007; 88: 264 – 274 .
33.
33 Antony JM Izad M Bar-Or A Warren KG Vodjgani M Mallet F . Quantitative analysis of human endogenous retrovirus-W Env in neuroinflammatory diseases.AIDS Res Hum Retroviruses2006; 22: 1253 – 1259 .
34.
34 Perron H Lazarini F Ruprecht K Pechoux-Longin C Seilhean D Sazdovitch V . Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.J Neurovirol2005; 11: 23 – 33 .
35.
35 Rolland A Jouvin-Marche E Saresella M Ferrante P Cavaretta R Creange A . Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.J Neuroimmunol2005; 160: 195 – 203 .
36.
36 Nelson PN Hooley P Roden D Ejtehadi H Rylance P Warren P . Human endogenous retroviruses: transposable elements with potential?Clin Exp Immunol2004; 138: 1 – 9 .
37.
37 Martin MA Bryan T Rasheed S Khan AS . Identification and cloning of endogenous retroviral sequences present in human DNA.Proc Natl Acad Sci USA1981; 78: 4892 – 4896 .
38.
38 Christensen T . Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.Rev Med Virol2005; 15: 179 – 211 .
39.
39 Brudek T Christensen T Hansen HJ Bobecka J Moller-Larsen A . Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis.AIDS Res Hum Retroviruses2004; 20: 415 – 423 .
40.
40 Ruprecht K Obojes K Wengel V Gronen F Kim KS Perron H . Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis.J Neurovirol2006; 12: 65 – 71 .
41.
41 Brudek T Luhdorf P Christensen T Hansen HJ Moller-Larsen A . Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV.J Neuroimmunol2007; 187: 147 – 155 .
42.
42 Christensen T Petersen T Thiel S Brudek T Ellermann-Eriksen S Moller-Larsen A . Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway.J Neuroimmunol2007; 183: 175 – 188 .
43.
43 Gooskens J Templeton KE Claas EC van Bussel MJ Smit VT Kroes AC . Quantitative detection of herpes simplex virus DNA in the lower respiratory tract.J Med Virol2007; 79: 597 – 604 .
44.
44 Wagner HJ Wessel M Jabs W Smets F Fischer L Offner G . Patients and risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein–Barr viral load by using real-time polymerase chain reaction.Transplantation2001; 72: 1012 – 1019 .
45.
45 Ishizaki Y Tezuka J Ohga S Nomura A Suga N Kuromaru R . Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella.Journal of Infection2003; 47: 133 – 138 .
46.
46 Guiver M Fox AJ Mutton K Mogulkoc N Egan J . Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients.Transplantation2001; 71: 1609 – 1615 .
47.
47 Hymasa W Stevenson J Taggart EW Hillyard D . Use of lyophilized standards for the calibration of a newly developed real time PCR assay for human herpes type six (HHV6) variants A and B.J Virol Methods2005; 128: 143 – 150 .
48.
48 Forsman A Yun Z Hu L Uzhameckis D Jern P Blomberg J . Development of broadly targeted human endogenous gammaretroviral pol-based real time PCRs. Quantitation of RNA expression in human tissues.J Virol Methods2005; 129: 16 – 30 .
49.
49 Nitsche A Müller CW Radonic A Landt O Ellerbrok H Pauli G . Human herpesvirus 6A DNA is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation.J Infect Dis2001; 183: 130 – 133 .
50.
50 Cuomo L Trivedi P Cardillo MR Gagliardi FM Vecchione A Caruso R . Human herpesvirus 6 infection in neoplastic and normal brain tissue.J Med Virol2001; 63: 45 – 51 .
51.
51 Knox KK Carrigan DR . Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS.J Acquir Immune Defic Syndr Hum Retrovirol1995; 9: 69 – 73 .
52.
52 Akhyani N Berti R Brennan MB Soldan SS Eaton JM McFarland HF . Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis.J Infect Dis2000; 182: 1321 – 1325 .
53.
53 Hall CB Caserta MT Schnabel KC Long C Epstein LG Insel RA . Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A.Clin Infect Dis1998: 26: 132 – 137 .
54.
54 Clark D . Human herpesvirus Type 6 and Multiple Sclerosis.Herpes2004; 11: 112A – 119A .
55.
55 Fillet AM Lozeron P Agut H Lyon-Caen O Liblau R . HHV-6 and multiple sclerosis.Nat Med1998; 4: 537 – 538 .
56.
56 Wilborn F Schmidt CA Brinkmann V Jendroska K Oettle H Siegert W . A potential role for human herpesvirus type 6 in nervous system disease.J Neuroimmunol1994; 49: 213 – 214 .
57.
57 Ablashi DV Lapps W Kaplan M Whitman JE Richert JR Pearson GR . Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report.Mult Scler1998; 4: 490 – 496 .
58.
58 Rotola A Merlotti I Caniatti L Caselli E Granieri E Tola MR . Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease.Mult Scler2004; 10: 348 – 354 .
59.
59 Tejada-Simon MV Zang YC Hong J Rivera VM Killian JM Zhang JZ . Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls.J Virol2002; 76: 6147 – 6154 .
60.
60 Fotheringham J Jacobson S . Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease.Herpes2005; 12: 4 – 9 .
61.
61 Perron H Garson JA Bedin F Beseme F Paranhos-Baccala G Komurian-Pradel F . Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis.Proc Natl Acad Sci U S A1997; 94: 7583 – 7588 .
62.
62 Dolei A Serra C Mameli G Pugliatti M Sechi G Cirotto MC . Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.Neurology2002; 58: 471 – 473 .
63.
63 Sotgiu S Serra C Mameli G Pugliatti M Rosati G Arru G . Multiple sclerosis-associated retrovirus and MS prognosis.Neurology2002; 59: 1071 – 1073 .
64.
64 Sotgiu S Arru G Soderstrom M Mameli G Serra C Dolei A . Multiple sclerosis-associated retrovirus and optic neuritis.Mult Scler2006; 12: 357 – 359 .
65.
65 Sotgiu S Pugliatti M Fois ML Arru G Sanna A Sotgiu MA . Genes, environment, and susceptibility to multiple sclerosis.Neurobiol Dis2004; 17: 131 – 143 .
66.
66 DeBiasi RL Tyler KL . Molecular methods for diagnosis of viral encephalitis.Clin Microbiol Rev2004; 17: 903 – 925 .
